QUOTED. 14 October 2019. Cecilia Wolyniak.
Executive Summary
At a recent industry meeting, US FDA recall officials emphasized that, contrary to what some device-makers may believe, there’s no requirement that recall documentation be submitted on paper, rather than electronically. See what Cecilia Wolyniak, the agency's recall team leader, said about it here.
You may also be interested in...
Compliance Corner: FDA Officials Share Tips To Ensure A Smooth Recall
Officials in the US FDA's recall divisions advised manufacturers on the best ways to work with the agency during the recalls process, including keeping track of who they're speaking with, making sure all required forms are complete, and not being afraid to use eSubmit.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.